Cargando…
Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate-to-severe ARDS—a randomized, placebo-controlled, double-blind trial
BACKGROUND: Acute respiratory distress syndrome (ARDS) is a complex clinical diagnosis with various possible etiologies. One common feature, however, is pulmonary permeability edema, which leads to an increased alveolar diffusion pathway and, subsequently, impaired oxygenation and decarboxylation. A...
Autores principales: | Schmid, Benedikt, Kredel, Markus, Ullrich, Roman, Krenn, Katharina, Lucas, Rudolf, Markstaller, Klaus, Fischer, Bernhard, Kranke, Peter, Meybohm, Patrick, Zwißler, Bernhard, Frank, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450703/ https://www.ncbi.nlm.nih.gov/pubmed/34544463 http://dx.doi.org/10.1186/s13063-021-05588-9 |
Ejemplares similares
-
Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate to severe ARDS in a randomized, placebo-controlled, double-blind trial: preliminary evaluation of safety and feasibility in light of the COVID-19 pandemic
por: Schmid, Benedikt, et al.
Publicado: (2022) -
Conformational ensemble of the TNF-derived peptide solnatide in solution
por: Martin-Malpartida, Pau, et al.
Publicado: (2022) -
Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study
por: Schlesinger, Tobias, et al.
Publicado: (2020) -
Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: a phase IIa randomized placebo-controlled trial
por: Krenn, Katharina, et al.
Publicado: (2017) -
Unconventional approaches to mechanical ventilation—step-by-step through the COVID-19 crisis
por: Lotz, Christopher, et al.
Publicado: (2020)